Claims for Patent: 11,097,063

Summary for Patent: 11,097,063

Title:	Syringe device with a dose limiting mechanism and an additional safety mechanism
Abstract:	A syringe device for ejecting a dose of a medicament, the syringe device comprising: a dose limiting mechanism arranged to interact with a dose ejecting mechanism to prevent ejection of a dose exceeding a set dose, and a safety mechanism, which is arranged such with respect to the dose ejecting mechanism that, if the dose limiting mechanism fails, the safety mechanism prevents ejection of a dose exceeding the set dose.
Inventor(s):	Eiland Jacob, Enggaard Christian Peter, Moeller Claus Schmidt, Markussen Tom Hede
Assignee:	Novo Nordisk A/S
Application Number:	US16250620
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 11,097,063
Patent Claims:

Details for Patent 11,097,063

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	June 16, 2005		2039-01-17
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	October 31, 2013		2039-01-17
Novo Nordisk Inc.	NOVOLOG MIX 50/50	insulin aspart protamine and insulin aspart	Injectable Suspension	021810	August 26, 2008		2039-01-17
Seqirus Inc.	FLUAD	influenza vaccine, adjuvanted	Injection	125510	November 24, 2015		2039-01-17
Seqirus Inc.	FLUAD,FLUAD QUADRIVALENT	influenza vaccine, adjuvanted	Injection	125510	February 21, 2020		2039-01-17
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	September 25, 2015		2039-01-17
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	November 21, 2018		2039-01-17

International Patent Family for US Patent 11,097,063

Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2007017053
United States of America	2025195784
United States of America	2021346606
United States of America	2019192783
United States of America	2008234634
United States of America	12268854
United States of America	10220155